
7 New Pancreatic Cancer Clinical Trials — August 2026
KRAS-targeted immune treatments move earlier in care, while surgery gets a light-activated treatment strategy
Your concise scan of the latest breakthroughs & new trials for pancreatic cancer.
Live Last read · last published · next check

KRAS-targeted immune treatments move earlier in care, while surgery gets a light-activated treatment strategy

Precision targeting (KRAS and beyond), novel cell therapies, advanced imaging, and emerging strategies across pancreatic cancer

KRAS drugs, targeted delivery, immune-cell therapies, and new options for pancreatic cancer after surgery, before surgery, and after standard treatments.

Our first issue. The month's new pancreatic cancer trials in plain English—organized so you can act and share.

This is Pancreatic Cancer Briefing.